查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1746731

日本血浆分馏市场报告（按产品、产业、应用、最终用户和地区）2025-2033

Japan Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年，日本血浆分离市场规模达9.029亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到17.023亿美元，2025-2033年期间的复合年增长率（CAGR）为6.7%。政府机构越来越重视引进经济高效的病毒灭活技术，以安全利用本地血浆资源，这是推动市场成长的主要动力。

血浆分离是将捐赠血浆转化为至关重要的救命治疗药物和医疗产品的过程。它涉及透过离心、深层过滤、沉淀和色谱等机械分离技术将血浆分离成单一蛋白质或血浆级分。在现代分离製程中，人们采用各种方法来分离特定的治疗性蛋白质，包括调整酒精浓度、时间、温度和pH值。此外，随着时间的推移，技术复杂性的提高以及在製造过程中实施病毒杀灭处理，催生了新型蛋白质疗法的出现，并提高了产品的纯度和品质。

日本血浆分馏市场趋势：

源自人体血浆的蛋白质产品是一类重要的治疗手段，广泛应用于预防、管理和治疗危及生命的疾病，包括感染、先天性缺陷、罕见血液疾病、免疫性疾病和自体免疫疾病。这些疾病在相当一部分人口中的盛行率大幅上升，是市场扩张的主要驱动力。此外，为了应对各国监管机构强制实施的严格法规和品质控制措施，製造商正在将额外的安全特性融入血浆分离流程，这对区域市场产生了积极影响。此外，市场利害关係人正在将资金投入到旨在推进血浆生产技术的研发项目中，从而成为重要的成长驱动因素。这些努力旨在提高产品功效，并促进免疫球蛋白G (IgG) 的回收，以分离新型血浆蛋白。此外，他们也致力于开发经济高效的病毒灭活和处理技术，以确保安全利用本地血浆资源。再加上对优化产量、维持製程成本效益和遵守日益严格的监管标准的日益增长的需求，这将在未来几年创造良好的市场前景。

日本血浆分馏市场细分：

产品洞察：

  • 免疫球蛋白
  • 白蛋白
  • 凝血因子VIII
  • 凝血因子 IX

产业洞察：

  • 私部门
  • 公部门

应用程式洞察：

  • 神经病学
  • 免疫学
  • 血液学
  • 其他的

最终用户洞察：

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本血浆分离市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本血浆分馏市场有何影响？
  • 日本血浆分离市场依产品划分是怎样的？
  • 日本血浆分离市场依产业分類的状况如何？
  • 日本血浆分离市场根据应用的细分是怎样的？
  • 根据最终用户，日本血浆分离市场是如何分類的？
  • 日本血浆分离市场的价值链分为哪些阶段？
  • 日本血浆分离技术的关键驱动因素和挑战是什么？
  • 日本血浆分离市场的结构是怎么样的？主要参与者是谁？
  • 日本血浆分离市场的竞争程度如何？

本报告回答的关键问题：

  • 日本血浆分离市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本血浆分馏市场有何影响？
  • 日本血浆分离市场依产品划分是怎样的？
  • 日本血浆分离市场依产业分類的状况如何？
  • 日本血浆分离市场根据应用的细分是怎样的？
  • 根据最终用户，日本血浆分馏市场是如何分類的？
  • 日本血浆分离市场的价值链分为哪些阶段？
  • 日本血浆分离技术的关键驱动因素和挑战是什么？
  • 日本血浆分离市场的结构是怎么样的？主要参与者是谁？
  • 日本血浆分离市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本血浆分离市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本血浆分离市场概况

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本血浆分离市场-细分：依产品

  • 免疫球蛋白
    • 概述
  • 白蛋白
    • 概述
  • 凝血因子VIII
    • 概述
  • 凝血因子 IX
    • 概述

第七章：日本血浆分离市场-细分：依行业

  • 私部门
    • 概述
  • 公部门
    • 概述

第 8 章：日本血浆分离市场 - 细分：按应用

  • 神经病学
    • 概述
  • 免疫学
    • 概述
  • 血液学
    • 概述
  • 其他的

第九章：日本血浆分离市场-细分：依最终用户

  • 医院和诊所
    • 概述
  • 临床研究实验室
    • 概述
  • 学术机构
    • 概述

第 10 章：日本血浆分馏市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第 11 章：关键参与者简介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 12 章：日本血浆分离市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章：附录

简介目录
Product Code: SR112025A18357

Japan plasma fractionation market size reached USD 902.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,702.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The rising focus among government bodies to introduce cost-effective viral inactivation technologies to safely utilize local plasma resources is primarily driving the market growth.

Plasma fractionation is the process of converting donated plasma into crucial life-saving treatments and medical products. It involves the division of plasma into individual proteins or plasma fractions through mechanical separation techniques like centrifugation, depth filtration, precipitation, and chromatography. In contemporary fractionation processes, various methods including alcohol concentrations, time, temperature, and pH adjustments are employed to isolate particular therapeutic proteins. Furthermore, the advancement of technology complexity over time and the implementation of viral reduction treatments during the manufacturing process have led to the emergence of novel protein therapies and enhancements in the purity and quality of products.

Japan Plasma Fractionation Market Trends:

Protein products derived from human plasma constitute a vital category of therapies extensively employed for the prevention, management, and treatment of life-threatening conditions, encompassing infections, congenital deficiencies, rare blood disorders, immunologic ailments, and autoimmune disorders. A significant upsurge in the prevalence of these conditions within a substantial portion of the population serves as a primary driver underpinning market expansion. Furthermore, manufacturers are incorporating added safety features into plasma fractionation procedures in response to stringent regulations and quality control measures mandated by regulatory agencies in numerous countries, which is positively influencing the regional market. Additionally, market stakeholders are directing financial resources towards research and development (R&D) initiatives aimed at advancing plasma production technology, thereby acting as significant growth-inducing factors. These endeavors aim to enhance product effectiveness and boost the recovery of immunoglobulin G (IgG) for the isolation of novel plasma proteins. Furthermore, they are focusing on developing cost-effective viral inactivation and processing technologies that enable the safe utilization of local plasma resources. This, in combination with the growing imperative to optimize yield, maintain process cost-efficiency, and comply with increasingly stringent regulatory standards, is poised to create a favorable market outlook in the forthcoming years.

Japan Plasma Fractionation Market Segmentation:

Product Insights:

  • Immunoglobulins
  • Albumin
  • Coagulation Factor VIII
  • Coagulation Factor IX

Sector Insights:

  • Private Sector
  • Public Sector

Application Insights:

  • Neurology
  • Immunology
  • Hematology
  • Others

End User Insights:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan plasma fractionation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan plasma fractionation market?
  • What is the breakup of the Japan plasma fractionation market on the basis of product?
  • What is the breakup of the Japan plasma fractionation market on the basis of sector?
  • What is the breakup of the Japan plasma fractionation market on the basis of application?
  • What is the breakup of the Japan plasma fractionation market on the basis of end user?
  • What are the various stages in the value chain of the Japan plasma fractionation market?
  • What are the key driving factors and challenges in the Japan plasma fractionation?
  • What is the structure of the Japan plasma fractionation market and who are the key players?
  • What is the degree of competition in the Japan plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Plasma Fractionation Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Plasma Fractionation Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Plasma Fractionation Market - Breakup by Product

  • 6.1 Immunoglobulins
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Albumin
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Coagulation Factor VIII
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Coagulation Factor IX
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)

7 Japan Plasma Fractionation Market - Breakup by Sector

  • 7.1 Private Sector
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Public Sector
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Plasma Fractionation Market - Breakup by Application

  • 8.1 Neurology
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Immunology
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Hematology
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Others
    • 8.4.1 Historical and Current Market Trends (2019-2024)
    • 8.4.2 Market Forecast (2025-2033)

9 Japan Plasma Fractionation Market - Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Clinical Research Laboratories
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Academic Institutes
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)

10 Japan Plasma Fractionation Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Services Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Services Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Services Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Services Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Services Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Plasma Fractionation Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix